OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Jianqing She, Gulinigaer Tuerhongjiang, Manyun Guo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 408-421.e5
Open Access | Times Cited: 17

Showing 17 citing articles:

Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis
Despina Giakomidi, Ayoola Ishola, Meritxell Nus
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access

The Role and Mechanism of Gut Microbiota in the Development of Diabetic Nephropathy
梅 韩
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 215-222
Closed Access

Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)
Yang Xiao, Bilian Yu, Chao Chen, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 4, pp. 325-343
Closed Access | Times Cited: 4

Emerging chemophysiological diversity of gut microbiota metabolites
Xiaorong Lin, Kaixin He, Zhen Gu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 824-838
Closed Access | Times Cited: 3

A gut feeling of statin
Jianqing She, Lizhe Sun, Yue Yu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 2

The effect of supplementation of vitamin D on hyperlipidemia and bone mass in the pediatric with obesity
Feifan Wang, Lingshan Bei, Xiaoyan Zhang, et al.
Critical Reviews in Immunology (2024) Vol. 45, Iss. 1, pp. 31-39
Closed Access | Times Cited: 1

Peptide GLP-1 receptor agonists: From injection to oral delivery strategies
Zhiqiang Ke, Qianqian Ma, Xiaonan Ye, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116471-116471
Closed Access | Times Cited: 1

Influence of Postoperative Insulin Resistance on Short-Term Outcomes of Radical Gastrectomy for Gastric Cancer: A Microbiome and Metabolome-Based Prospective Cohort Study
Zhipeng He, Huan Xiong, Lulin Liu, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 13, pp. 8638-8650
Closed Access | Times Cited: 1

Statin Use and Hyperglycemia: Do Statins Cause Diabetes?
Cindy Bredefeld, Paula Choi, Tiffany Cullen, et al.
Current Atherosclerosis Reports (2024) Vol. 27, Iss. 1
Closed Access

Page 1

Scroll to top